7 Myths About the Coronavirus Vaccine Don’t be fooled

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
178
7 Myths About the Coronavirus Vaccine

Don’t be fooled by bad information or irrational skepticism. Get your shots as soon as possible.

Aaron E. Carroll



Dr. Carroll is a professor of pediatrics at Indiana University School of Medicine and a contributing opinion writer. He writes often on health research and policy.
Feb. 13, 2021

As the vaccines for the coronavirus become more ubiquitous, so do misinformation, myths and misconceptions about them. This is unfortunate, because these untruths delay acceptance of the vaccines, and widespread immunization is the fastest and best way to begin to return to a more normal way of life. Seven of the most common myths I’ve heard from patients, friends and colleagues follow, along with my rebuttals.

The vaccine hurts fertility, especially in young people.

For some reason, this is the most common false assertion I hear. Sometime last year, a German doctor and a former Pfizer employee raised a concern that the coronavirus’s spike protein — the material that makes up those sharp protruding bumps you see in depictions of the virus — was in some ways similar to a protein that is part of a healthy placenta’s functioning during pregnancy.

Therefore, they ventured, developing antibodies to the spike protein from a vaccine could lead to antibodies that might also attack a woman’s body when she was pregnant or trying to get pregnant, leading to complications. This theory is now widely circulated.

It is mistaken. The two spike proteins are distinct, and there is no evidence that the vaccination leads to antibodies that attack the placenta.

While the Pfizer trial of its vaccine attempted to exclude pregnant women, 23 pregnant women were a part of it, probably having gotten pregnant soon after vaccination. Two adverse events were seen in the trials: a spontaneous abortion and retained products of conception (placental or fetal tissue that remains in the uterus, often after miscarriage); both occurred in the placebo group. Anthony Fauci, President Biden’s chief medical adviser for the pandemic, said on Wednesday that more than 10,000 pregnant women have received the vaccine with “thus far no red flags.”

Once you’re vaccinated, you can go back to normal, pre-pandemic life .

This is, unfortunately, not true. I cannot stress enough how amazing the vaccines are: Those that are approved are proven to prevent symptomatic disease, as well as bad outcomes like hospitalizations or death.

But we don’t yet know whether they prevent asymptomatic infections. It is possible that vaccinated people could still become infected, be unaware and spread the coronavirus to others.

We hope to find out soon if this possibility is real or not; some of the early information coming out of other countries looks promising. But until we know with greater certainty, we still need everyone — even those who are immunized — to mask up, distance from others and remain careful.

When we hit herd immunity, this will all be over.

Herd immunity refers to a situation where enough protection exists in a community that exponential growth of infections is highly unlikely, if not impossible. The concept is usually discussed when diseases are rare, as with measles.

Herd immunity will protect us from large numbers of Covid-19 cases only once we have suppressed the disease. Nowhere in the United States are we near this point, though. The coronavirus is still hugely prevalent, and new variants may be even more contagious.

As communities achieve herd immunity, they will see slightly less Covid-19 the next day than they did the day before. It will not disappear overnight. Herd immunity will signal the beginning of the end of the pandemic — not the day we are done with it.

Side effects of this vaccine are much more severe than those of typical vaccines.

Allergic reactions are not a reason to avoid vaccination. Very few people given the vaccine have experienced anaphylaxis, a severe allergic reaction. More have experienced symptoms like aches, chills, pain and fever, but those symptoms are not usually worrisome: They are often signs that your body’s immune system is working. More severe occurrences, like deaths in frail, older patients, need to be investigated, but it’s entirely possible that this is a coincidence and not unexpected in that population.

In coronavirus vaccine studies, Bell’s palsy has seemed to occur more often in people who received the vaccine than in those who received the placebo. (Bell’s palsy is a temporary weakness or mild paralysis, usually affecting one side of the face.) It’s important to note, however, that among the general population, Bell’s palsy appears in about 15 to 20 people per 100,000 people each year. That is a higher rate than what occurred in the trials: Four of the 30,000 people in the Moderna trial (one in the placebo group) and four of the 44,000 people in the Pfizer trial developed Bell’s palsy.

The studies were rushed, and corners were cut.

First of all, more scientists were probably working on this one thing than have ever collectively focused on any one thing in the history of the world. We should expect progress.

We also had a number of head starts. A lot of exploratory and preclinical work had already been done on coronavirus vaccines because of SARS, or severe acute respiratory syndrome. In addition, because of significant public investment and a guaranteed worldwide market, many companies immediately devoted lots of resources to this task.

To be approved by the Food and Drug Administration in the United States, vaccines must clear three phases of study. The first is small (likely tens of people) and focuses on safety. The second is larger (maybe hundreds of people), involves people who have known risks for the disease and focuses on safety and whether there is some sort of biological response (specifically, antibody production).

Phase 3 involves large, randomized controlled trials (thousands to tens of thousands of people) that focus on effectiveness (that is, preventing illness) and side effects. With coronavirus vaccines, the process was highly accelerated, but all of these phases were completed and were reviewed by the Food and Drug Administration.

We’re also focusing (appropriately) on the few vaccine successes. Many companies failed or haven’t succeeded yet. Those vaccines that made it through the gantlet were thoroughly studied and found to be safe and effective.

Covid-19 is less dangerous than the vaccine.

People hear of the risks of side effects and assume they’re better off not getting vaccinated. They’re comparing those risks to perfect health instead of to the risk of Covid-19 itself. But assuming perfect health is unwarranted: Covid is prevalent and dangerous.

A vaccine that is ‘only’ 70 percent effective isn’t worth it.

As with so many things in public health, don’t let the perfect be the enemy of the good. It’s great that in trials the Moderna and Pfizer vaccines have been about 95 percent effective against symptomatic disease, but that level of effectiveness is not necessary. In trials Jonas Salk’s polio vaccine was 80 percent to 90 percent effective, and it changed the world.

This is a version of the perception problem that the flu vaccine faces every year. People refuse to get it because it’s not “good enough.” They miss that it’s “good.” The more people who get vaccinated, the more morbidity and mortality we avoid. The best coronavirus vaccine is the one you can get as soon as possible.

The Times is committed to publishing a diversity of letters to the editor. We’d like to hear what you think about this or any of our articles. Here are some tips. And here’s our email: letters@nytimes.com.

https://www.nytimes.com/2021/02/13/opinion/co...e9f650852d
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 5

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 6

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
PayPal Under Investigation: Legal Battles Intensify

Updated Category News Views 3

A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...

Continue Reading
Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 2

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 4

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
2026 Lantern Festival Shines in Kunshan Amid Tensions

Updated Category News Views 4

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 5

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 5

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
BarrelPick.com Launches for Bourbon Aficionados

Updated Category News Views 4

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Continue Reading
Fast Guard Elevates Nationwide Fire Watch Mission

Updated Category News Views 2

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuit Against Allarity Therapeutics: Key Updates

Updated Category News Views 54

Class Action Lawsuit Update for Allarity Therapeutics, Inc. Allarity Therapeutics, Inc. is currently facing a securities class action lawsuit that affects many investors. This important legal case is taking place in the United States District Court, drawing attention to the company's actions during a specific time frame. Details of the Class Action Lawsuit Investors who...

Continue Reading
Artisight Introduces Innovative Voice-Activated Interpreters

Updated Category News Views 219

Artisight's New Voice-Activated Interpreter Feature Artisight has taken a significant step forward in improving healthcare communication by launching its Voice-Activated Interpreter feature on the Smart Hospital Platform. This innovative technology allows clinicians to engage with patients in numerous languages effortlessly. With a simple voice command, healthcare...

Continue Reading
Rigetti Computing Showcases Strong Q1 2025 Performance Metrics

Updated Category News Views 1209

Rigetti Computing Highlights Impressive Q1 2025 Performance Rigetti Computing, Inc. (Nasdaq: RGTI) is on an impressive trajectory, recently reporting its financial results for the first quarter of 2025, showcasing its ongoing advancements in the realm of quantum-classical computing technology. Financial Performance Overview Here are the key highlights from Rigetti's...

Continue Reading
Transforming the Cannabis Experience: The Flavorizers Revolution

Updated Category News Views 902

Revolutionizing Cannabis Consumption Relavor BioPharmaceutical Labs, a pioneering name in the cannabis and medical aerosol sectors, has recently introduced a groundbreaking product called Flavorizers. This extraordinary innovation is designed to transform the way cannabis flower vapor is consumed, setting itself apart in a booming multi-billion dollar market. Introducing...

Continue Reading
Protect Pharmaceutical Corp. Terminates KARINCA Logistics Merger

Updated Category News Views 91

Protect Pharmaceutical Corp. Announces Termination of Merger Protect Pharmaceutical Corp. (OTC: PRTT) has announced that its planned merger with KARINCA Logistics will not move forward. This decision came after a thorough review during the final stages of the due diligence process, where unexpected business challenges were identified. Management's Dedication to...

Continue Reading